Circulating microRNAs in Early Breast Cancer Patients and Its Association With Lymph Node Metastases
Open Access
- 26 August 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
Abstract
MicroRNAs have emerged as important regulators of the metastatic process. In addition, circulating miRNAs appear to be surprisingly stable in peripheral blood making them ideal noninvasive biomarkers for disease diagnosis. Here, we performed a proof-of-principle study to investigate the expression profile of circulating miRNAs and their association with the metastatic lymph node status in early breast cancer patients. Sentinel lymph node status was detected by one-step nucleic acid (OSNA) analysis. We performed RNA-sequencing in 16 plasma samples and validated the results by qPCR. Gene Ontology term enrichment and KEGG pathway analyses were carried out using DAVID tools. We found16 differentially expressed miRNAs (q < 0.01) in patients with positive SLNs. Fourteen miRNAs were down-regulated (miR-339-5p, miR-133a-3p, miR-326, miR-331-3p, miR-369-3p, miR-328-3p, miR-26a-3p, miR-139-3p, miR-493-3p, miR-664a-5p, miR-146a-5p, miR-323b-3p, miR-1307-3p and miR-423-3p) and 2 were up-regulated (miR-101-3pand miR-144-3p). Hierarchical clustering using differentially expressed miRNAs clearly distinguished patients according to their lymph node status. Gene ontology analysis showed a significant enrichment of biological processes associated with the regulation of the epithelial mesenchymal transition, cell proliferation and transcriptional regulation. Our results suggest the potential role of several circulating miRNAs as surrogate markers of lymph node metastases in early breast cancer patients. Further validation in a larger cohort of patients will be necessary to confirm our results.Keywords
All Related Versions
Funding Information
- Instituto de Salud Carlos III (PI13/00110, PI19/00362, RTICC: RD12/0036/0076)
- European Regional Development Fund (PI19/00362, PI13/00119)
- Centro de Investigación Biomédica en Red de Cáncer (CB16/12/00471)
This publication has 66 references indexed in Scilit:
- MiR-339-5p Regulates the Growth, Colony Formation and Metastasis of Colorectal Cancer Cells by Targeting PRL-1PLOS ONE, 2013
- Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancerJournal of Cancer Research and Clinical Oncology, 2012
- MiRPara: a SVM-based software tool for prediction of most probable microRNA coding regions in genome scale sequencesBMC Bioinformatics, 2011
- MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosisBMC Cancer, 2010
- A scaling normalization method for differential expression analysis of RNA-seq dataGenome Biology, 2010
- The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variantsNucleic Acids Research, 2009
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Causes and consequences of microRNA dysregulation in cancerNature Reviews Genetics, 2009
- Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in CancerScience, 2008
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991